Global and China Organ Transplant Immunosuppressant Drugs Market Insights, Forecast to 2027

Global and China Organ Transplant Immunosuppressant Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Organ Transplant Immunosuppressant Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Organ Transplant Immunosuppressant Drugs Market Size Growth Rate by Type
1.2.2 Antibodies
1.2.3 Antiproliferative Agents
1.2.4 Calcineurin Inhibitors
1.2.5 mTOR Inhibitors
1.2.6 Steroids
1.3 Market by Application
1.3.1 Global Organ Transplant Immunosuppressant Drugs Market Size Growth Rate by Application
1.3.2 Bone Marrow Transplant
1.3.3 Heart Transplant
1.3.4 Kidney Transplant
1.3.5 Liver Transplant
1.3.6 Lung Transplant
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Organ Transplant Immunosuppressant Drugs Market Size, Estimates and Forecasts
2.1.1 Global Organ Transplant Immunosuppressant Drugs Revenue 2016-2027
2.1.2 Global Organ Transplant Immunosuppressant Drugs Sales 2016-2027
2.2 Global Organ Transplant Immunosuppressant Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Organ Transplant Immunosuppressant Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Organ Transplant Immunosuppressant Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Organ Transplant Immunosuppressant Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Organ Transplant Immunosuppressant Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Region (2022-2027)
3 Global Organ Transplant Immunosuppressant Drugs Competitor Landscape by Players
3.1 Global Top Organ Transplant Immunosuppressant Drugs Manufacturers by Sales
3.1.1 Global Organ Transplant Immunosuppressant Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Organ Transplant Immunosuppressant Drugs Manufacturers by Revenue
3.2.1 Key Organ Transplant Immunosuppressant Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Organ Transplant Immunosuppressant Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Organ Transplant Immunosuppressant Drugs Revenue in 2020
3.2.6 Global Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Organ Transplant Immunosuppressant Drugs Price by Manufacturers
3.4 Global Organ Transplant Immunosuppressant Drugs Manufacturing Base Distribution, Product Types
3.4.1 Organ Transplant Immunosuppressant Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Organ Transplant Immunosuppressant Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Organ Transplant Immunosuppressant Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Organ Transplant Immunosuppressant Drugs Market Size by Type (2016-2021)
4.1.1 Global Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2021)
4.1.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2016-2021)
4.1.3 Organ Transplant Immunosuppressant Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Organ Transplant Immunosuppressant Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Organ Transplant Immunosuppressant Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Organ Transplant Immunosuppressant Drugs Market Size by Application (2016-2021)
5.1.1 Global Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2021)
5.1.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2016-2021)
5.1.3 Organ Transplant Immunosuppressant Drugs Price by Application (2016-2021)
5.2 Organ Transplant Immunosuppressant Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Organ Transplant Immunosuppressant Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Organ Transplant Immunosuppressant Drugs Market Size YoY Growth 2016-2027
6.1.1 China Organ Transplant Immunosuppressant Drugs Sales YoY Growth 2016-2027
6.1.2 China Organ Transplant Immunosuppressant Drugs Revenue YoY Growth 2016-2027
6.1.3 China Organ Transplant Immunosuppressant Drugs Market Share in Global Market 2016-2027
6.2 China Organ Transplant Immunosuppressant Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Organ Transplant Immunosuppressant Drugs Players by Sales (2016-2021)
6.2.2 China Top Organ Transplant Immunosuppressant Drugs Players by Revenue (2016-2021)
6.3 China Organ Transplant Immunosuppressant Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Organ Transplant Immunosuppressant Drugs Price by Type (2016-2021)
6.4 China Organ Transplant Immunosuppressant Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Organ Transplant Immunosuppressant Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Organ Transplant Immunosuppressant Drugs Price Forecast by Type (2022-2027)
6.5 China Organ Transplant Immunosuppressant Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Organ Transplant Immunosuppressant Drugs Price by Application (2016-2021)
6.6 China Organ Transplant Immunosuppressant Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Organ Transplant Immunosuppressant Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Organ Transplant Immunosuppressant Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Organ Transplant Immunosuppressant Drugs Market Size YoY Growth 2016-2027
7.2 North America Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
7.2.1 North America Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021)
7.2.2 North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Organ Transplant Immunosuppressant Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Organ Transplant Immunosuppressant Drugs Market Size YoY Growth 2016-2027
9.2 Europe Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
9.2.1 Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021)
9.2.2 Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Organ Transplant Immunosuppressant Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
10.2.1 Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021)
10.2.2 Latin America Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Organ Transplant Immunosuppressant Drugs Products Offered
12.1.5 Roche Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi Organ Transplant Immunosuppressant Drugs Products Offered
12.2.5 Sanofi Recent Development
12.3 Astellas Pharma, Inc.
12.3.1 Astellas Pharma, Inc. Corporation Information
12.3.2 Astellas Pharma, Inc. Description and Business Overview
12.3.3 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Products Offered
12.3.5 Astellas Pharma, Inc. Recent Development
12.4 GlaxoSmithKline plc
12.4.1 GlaxoSmithKline plc Corporation Information
12.4.2 GlaxoSmithKline plc Description and Business Overview
12.4.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Products Offered
12.4.5 GlaxoSmithKline plc Recent Development
12.5 Novartis AG
12.5.1 Novartis AG Corporation Information
12.5.2 Novartis AG Description and Business Overview
12.5.3 Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Novartis AG Organ Transplant Immunosuppressant Drugs Products Offered
12.5.5 Novartis AG Recent Development
12.6 Pfizer, Inc.
12.6.1 Pfizer, Inc. Corporation Information
12.6.2 Pfizer, Inc. Description and Business Overview
12.6.3 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Products Offered
12.6.5 Pfizer, Inc. Recent Development
12.7 Veloxis Pharmaceuticals
12.7.1 Veloxis Pharmaceuticals Corporation Information
12.7.2 Veloxis Pharmaceuticals Description and Business Overview
12.7.3 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Products Offered
12.7.5 Veloxis Pharmaceuticals Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Roche Organ Transplant Immunosuppressant Drugs Products Offered
12.11.5 Roche Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Organ Transplant Immunosuppressant Drugs Industry Trends
13.2 Organ Transplant Immunosuppressant Drugs Market Drivers
13.3 Organ Transplant Immunosuppressant Drugs Market Challenges
13.4 Organ Transplant Immunosuppressant Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Organ Transplant Immunosuppressant Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Organ Transplant Immunosuppressant Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Antibodies
Table 3. Major Manufacturers of Antiproliferative Agents
Table 4. Major Manufacturers of Calcineurin Inhibitors
Table 5. Major Manufacturers of mTOR Inhibitors
Table 6. Major Manufacturers of Steroids
Table 7. Global Organ Transplant Immunosuppressant Drugs Market Size Growth Rate by Application (2021-2027) & (K Doses)
Table 8. Global Organ Transplant Immunosuppressant Drugs Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Organ Transplant Immunosuppressant Drugs Sales by Regions (2016-2021) & (K Doses)
Table 10. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Regions (2016-2021)
Table 11. Global Organ Transplant Immunosuppressant Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Region (2022-2027) & (K Doses)
Table 13. Global Organ Transplant Immunosuppressant Drugs Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2016-2021) (K Doses)
Table 17. Global Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Organ Transplant Immunosuppressant Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 19. Organ Transplant Immunosuppressant Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers (2016-2021)
Table 21. Global Organ Transplant Immunosuppressant Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Organ Transplant Immunosuppressant Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Organ Transplant Immunosuppressant Drugs as of 2020)
Table 23. Key Manufacturers Organ Transplant Immunosuppressant Drugs Price (2016-2021) (USD/ Dose)
Table 24. Organ Transplant Immunosuppressant Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Organ Transplant Immunosuppressant Drugs Product Type
Table 26. Date of International Manufacturers Enter into Organ Transplant Immunosuppressant Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Organ Transplant Immunosuppressant Drugs Sales by Type (2016-2021) (K Doses)
Table 29. Global Organ Transplant Immunosuppressant Drugs Sales Share by Type (2016-2021)
Table 30. Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2016-2021)
Table 32. Organ Transplant Immunosuppressant Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/ Dose)
Table 33. Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2022-2027) & (K Doses)
Table 34. Global Organ Transplant Immunosuppressant Drugs Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Organ Transplant Immunosuppressant Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Organ Transplant Immunosuppressant Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/ Dose)
Table 38. Global Organ Transplant Immunosuppressant Drugs Sales by Application (2016-2021) (K Doses)
Table 39. Global Organ Transplant Immunosuppressant Drugs Sales Share by Application (2016-2021)
Table 40. Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Application (2016-2021)
Table 42. Organ Transplant Immunosuppressant Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/ Dose)
Table 43. Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2022-2027) & (K Doses)
Table 44. Global Organ Transplant Immunosuppressant Drugs Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Organ Transplant Immunosuppressant Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/ Dose)
Table 48. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) of Key Companies (2016-2021)
Table 49. China Organ Transplant Immunosuppressant Drugs Sales Share by Company (2016-2021)
Table 50. China Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) by Company (2016-2021)
Table 51. China Organ Transplant Immunosuppressant Drugs Revenue Share by Company (2016-2021)
Table 52. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2016-2021)
Table 53. China Organ Transplant Immunosuppressant Drugs Sales Share by Type (2016-2021)
Table 54. China Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. China Organ Transplant Immunosuppressant Drugs Price (USD/ Dose) by Type (2016-2021)
Table 56. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2022-2027)
Table 57. China Organ Transplant Immunosuppressant Drugs Sales Share by Type (2022-2027)
Table 58. China Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. China Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2022-2027)
Table 60. China Organ Transplant Immunosuppressant Drugs Price (USD/ Dose) by Type (2022-2027)
Table 61. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2016-2021)
Table 62. China Organ Transplant Immunosuppressant Drugs Sales Share by Application (2016-2021)
Table 63. China Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. China Organ Transplant Immunosuppressant Drugs Price (USD/ Dose) by Application (2016-2021)
Table 65. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2022-2027)
Table 66. China Organ Transplant Immunosuppressant Drugs Sales Share by Application (2022-2027)
Table 67. China Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. China Organ Transplant Immunosuppressant Drugs Revenue Share by Application (2022-2027)
Table 69. China Organ Transplant Immunosuppressant Drugs Price (USD/ Dose) by Application (2022-2027)
Table 70. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021) & (K Doses)
Table 71. North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2016-2021)
Table 72. North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2016-2021) & (K Doses)
Table 75. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2016-2021)
Table 78. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021) & (K Doses)
Table 79. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2016-2021)
Table 80. Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2016-2021)
Table 82. Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021) & (K Doses)
Table 83. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021) & (K Doses)
Table 87. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2016-2021)
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2016-2021)
Table 93. Roche Organ Transplant Immunosuppressant Drugs Product
Table 94. Roche Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2016-2021)
Table 98. Sanofi Product
Table 99. Sanofi Recent Development
Table 100. Astellas Pharma, Inc. Corporation Information
Table 101. Astellas Pharma, Inc. Description and Business Overview
Table 102. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2016-2021)
Table 103. Astellas Pharma, Inc. Product
Table 104. Astellas Pharma, Inc. Recent Development
Table 105. GlaxoSmithKline plc Corporation Information
Table 106. GlaxoSmithKline plc Description and Business Overview
Table 107. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2016-2021)
Table 108. GlaxoSmithKline plc Product
Table 109. GlaxoSmithKline plc Recent Development
Table 110. Novartis AG Corporation Information
Table 111. Novartis AG Description and Business Overview
Table 112. Novartis AG Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2016-2021)
Table 113. Novartis AG Product
Table 114. Novartis AG Recent Development
Table 115. Pfizer, Inc. Corporation Information
Table 116. Pfizer, Inc. Description and Business Overview
Table 117. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2016-2021)
Table 118. Pfizer, Inc. Product
Table 119. Pfizer, Inc. Recent Development
Table 120. Veloxis Pharmaceuticals Corporation Information
Table 121. Veloxis Pharmaceuticals Description and Business Overview
Table 122. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2016-2021)
Table 123. Veloxis Pharmaceuticals Product
Table 124. Veloxis Pharmaceuticals Recent Development
Table 125. Organ Transplant Immunosuppressant Drugs Market Trends
Table 126. Organ Transplant Immunosuppressant Drugs Market Drivers
Table 127. Organ Transplant Immunosuppressant Drugs Market Challenges
Table 128. Organ Transplant Immunosuppressant Drugs Market Restraints
Table 129. Organ Transplant Immunosuppressant Drugs Customers List
Table 130. Organ Transplant Immunosuppressant Drugs Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Organ Transplant Immunosuppressant Drugs Product Picture
Figure 2. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Antibodies Product Picture
Figure 4. Antiproliferative Agents Product Picture
Figure 5. Calcineurin Inhibitors Product Picture
Figure 6. mTOR Inhibitors Product Picture
Figure 7. Steroids Product Picture
Figure 8. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application in 2020 & 2027
Figure 9. Bone Marrow Transplant
Figure 10. Heart Transplant
Figure 11. Kidney Transplant
Figure 12. Liver Transplant
Figure 13. Lung Transplant
Figure 14. Organ Transplant Immunosuppressant Drugs Report Years Considered
Figure 15. Global Organ Transplant Immunosuppressant Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Organ Transplant Immunosuppressant Drugs Market Size 2016-2027 (US$ Million)
Figure 17. Global Organ Transplant Immunosuppressant Drugs Sales 2016-2027 (K Doses)
Figure 18. Global Organ Transplant Immunosuppressant Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 19. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2016-2021)
Figure 20. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region in 2020
Figure 21. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2016-2021)
Figure 22. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region in 2020
Figure 23. Global Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturer in 2020
Figure 24. The Top 10 and 5 Players Market Share by Organ Transplant Immunosuppressant Drugs Revenue in 2020
Figure 25. Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2016-2021)
Figure 27. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2020
Figure 28. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2016-2021)
Figure 29. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type in 2020
Figure 30. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2016-2021)
Figure 31. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application in 2020
Figure 32. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2016-2021)
Figure 33. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application in 2020
Figure 34. China Organ Transplant Immunosuppressant Drugs Sales Growth Rate 2016-2027 (K Doses)
Figure 35. China Organ Transplant Immunosuppressant Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. China Organ Transplant Immunosuppressant Drugs Market Share in Global Market 2016-2027
Figure 37. China 5 and 10 Largest Organ Transplant Immunosuppressant Drugs Players Market Share by Revenue in Organ Transplant Immunosuppressant Drugs in 2020
Figure 38. China Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2016-2021)
Figure 39. China Organ Transplant Immunosuppressant Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 40. China Organ Transplant Immunosuppressant Drugs Revenue Share by Application (2016-2021)
Figure 41. China Organ Transplant Immunosuppressant Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America Organ Transplant Immunosuppressant Drugs Sales Growth Rate 2016-2021 (K Doses)
Figure 43. North America Organ Transplant Immunosuppressant Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 44. North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Country in 2020
Figure 45. North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country in 2020
Figure 46. U.S. Organ Transplant Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K Doses)
Figure 47. U.S. Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Canada Organ Transplant Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K Doses)
Figure 49. Canada Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Organ Transplant Immunosuppressant Drugs Sales Growth Rate 2016-2021 (K Doses)
Figure 51. Europe Organ Transplant Immunosuppressant Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Country in 2020
Figure 53. Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country in 2020
Figure 54. Germany Organ Transplant Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K Doses)
Figure 55. Germany Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. France Organ Transplant Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K Doses)
Figure 57. France Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. U.K. Organ Transplant Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K Doses)
Figure 59. U.K. Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Italy Organ Transplant Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K Doses)
Figure 61. Italy Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Russia Organ Transplant

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs